ArticleTherapeutic advances in respiratory disease
Impact of early therapeutic modality on 28-day mortality in immunocompromised patients with opportunistic pulmonary infections: a multicenter retrospective study.
Shiying Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.